Detalhe da pesquisa
1.
Correlation of HER2, FCGR2A, and FCGR3A gene polymorphisms with trastuzumab related cardiac toxicity and efficacy in a subgroup of patients from UNICANCER-PACS 04 trial.
Breast Cancer Res Treat
; 139(3): 789-800, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23780683
2.
Phase I and pharmacokinetic study of aplidine, a new marine cyclodepsipeptide in patients with advanced malignancies.
J Clin Oncol
; 23(31): 7871-80, 2005 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16172454
3.
Phase I study of pegylated liposomal doxorubicin in combination with ifosfamide in pretreated ovarian cancer patients.
Am J Clin Oncol
; 29(4): 399-404, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16891870
4.
Phase I-II study of pegylated liposomal doxorubicin combined with weekly paclitaxel as first-line treatment in patients with metastatic breast cancer.
Am J Clin Oncol
; 29(3): 267-75, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16755180
5.
A phase I and pharmacokinetic study of irofulven and cisplatin administered in a 30-min infusion every two weeks to patients with advanced solid tumors.
Invest New Drugs
; 24(4): 311-9, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16683074
6.
Phase I study with dose escalation of gemcitabine and cisplatin in combination with ifosfamide (GIP) in patients with non-small-cell lung carcinoma.
Am J Clin Oncol
; 27(1): 89-95, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-14758140